Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma

Fig. 2

Elevated KRS2 is associated with poor prognosis. A The expression of KSR2 in cancer tissues in TMA, expression in adjacent normal tissues, and H and E staining. B The relationship between overall survival and expression of KSR2 was analyzed by Kaplan–Meier analysis. C The relation between disease-free survival and expression of KSR2 was analyzed by Kaplan–Meier analysis. D, E Univariate and multivariate cox analysis of OS and DFS in HCC patients. F Western blot analysis of KSR2 protein levels in 10 pairs of fresh liver cancer and adjacent tissues. G qPCR analysis of the mRNA levels of KSR2 in five liver cancer cell lines. H Western blot analysis of the protein levels of KSR2 in five liver cancer cell lines

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us